Rare diseases
Investigational molecules
Locations
Back to Italy1 011 clinical trials in Arezzo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
ItalyRinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer
ItalyA Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer
ItalyStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
ItalyFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
ItalyA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
ItalyEvaluation of zongertinib, fulvestrant and goserelin acetate in patients with HR‑positive HER2‑negative advanced breast cancer
ItalyPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
ItalyA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
ItalyPhase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes
ItalyEfficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
ItalyEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies combining immunotherapy with established treatments. Studies evaluate new approaches for both muscle-invasive and non-muscle invasive disease.
Multiple trials exploring targeted treatments for patients with various stages of disease progression.
Advanced studies examining new therapeutic approaches for metastatic prostate cancer, including novel drug combinations and targeted therapies for specific genetic mutations.
Investigating innovative treatment sequences and combinations to improve patient outcomes.
Cutting-edge research in renal cell carcinoma treatment, exploring immunotherapy combinations and targeted approaches for both early-stage and metastatic disease.
Focus on improving survival rates through novel therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
